l 694247 has been researched along with sb 269970 in 1 studies
Studies (l 694247) | Trials (l 694247) | Recent Studies (post-2010) (l 694247) | Studies (sb 269970) | Trials (sb 269970) | Recent Studies (post-2010) (sb 269970) |
---|---|---|---|---|---|
32 | 0 | 8 | 192 | 0 | 99 |
Protein | Taxonomy | l 694247 (IC50) | sb 269970 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.0019 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Domingo, M; García-Pedraza, JÁ; Gómez-Roso, M; López, C; Martín, ML; Morán, A | 1 |
1 other study(ies) available for l 694247 and sb 269970
Article | Year |
---|---|
Fluoxetine oral treatment discloses 5-HT
Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Bradycardia; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoxetine; Heart; Heart Rate; Humans; Oxadiazoles; Phenols; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Sulfonamides; Tryptamines; Vagus Nerve | 2019 |